---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278123420.md"
description: "Servier agrees to acquire Day One Biopharmaceuticals for $2.5 billion, thereby entering the rare cancer field"
datetime: "2026-03-06T14:47:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278123420.md)
  - [en](https://longbridge.com/en/news/278123420.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278123420.md)
generator: "portal-rs"
---

# 

Servier agrees to acquire Day One Biopharmaceuticals for $2.5 billion, entering the rare cancer field

### Related Stocks

- [DAWN.US](https://longbridge.com/en/quote/DAWN.US.md)

## Related News & Research

- [‘SpaceX Stock Is in the Danger Zone,’ Says Investor](https://longbridge.com/en/news/301052732.md)
- [History Says Infrastructure Booms Create Winners and Losers. Here Are 3 AI Cloud Stocks to Watch.](https://longbridge.com/en/news/301060298.md)
- [Seagate vs. Western Digital vs. Toshiba: The AI Storage War Is Getting Serious](https://longbridge.com/en/news/301054654.md)
- [Oracle Corporation $ORCL Stock Holdings Decreased by Bank of New Hampshire](https://longbridge.com/en/news/301083742.md)
- ['Stop Dreaming,' Says Investor About Micron Stock](https://longbridge.com/en/news/300984156.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**